This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
THURSDAY, April 10, 2025 -- Five years after COVID-19 first hit the United States, scientists are already brainstorming how to stop the next big virus.One possible solution? A special kind of ultraviolet light called far-UVC, CBS News.
THURSDAY, April 10, 2025 -- An older persons hearing might be a harbinger of heart health, a new study says.People who experience hearing loss are more likely to develop heart failure, researchers reported April 8 in the journal Heart.Whats more.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
THURSDAY, April 10, 2025 -- Air pollution might be harming the brains of seniors, increasing their risk of dementia and cognitive decline, a new study says.Exposure to nitrogen dioxide and fine particle pollution is linked to lower scores in key.
Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical institutional knowledge at the FDA.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical institutional knowledge at the FDA.
THURSDAY, April 10, 2025 -- Having a father with Alzheimers disease could put you at risk for brain changes linked to the degenerative disorder, a new study says.People whose fathers fell prey to Alzheimers had a greater spread of tau proteins in.
"Just spent the morning digging into the world of pharmaceuticals and I'm blown away by the complexities of drafting effective drug patent applications. The team at Drug Patent Watch has done an incredible job of breaking down the key considerations for turning scientific discoveries into market power. From understanding the nuances of patent law to leveraging data-driven strategies, it's clear that the stakes are high in this space.
THURSDAY, April 10, 2025 -- Heavy drinkers have an increased risk of developing brain lesions associated with memory and thinking problems, a new study says.Folks who imbibe eight or more alcoholic drinks a week have an increased risk of hyaline.
A seminal study has uncovered a new genetic cause of neurodevelopmental disorders (NDDs). The discovery offers both closure and hope to potentially thousands of families worldwide who have long been searching for answers. The study reveals that mutations in a small, previously overlooked non-coding gene called RNU2-2 are responsible for relatively common NDD.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
THURSDAY, April 10, 2025 -- Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an acute postoperative inflammatory reaction.All lots of the following intraocular lens models in the.
Bioinformaticians have established that the genes in bacterial genomes are arranged in a meaningful order. They describe that the genes are arranged by function: If they become increasingly important at faster growth, they are located near the origin of DNA replication. Accordingly, their position influences how their activity changes with the growth rate.
THURSDAY, April 10, 2025 -- Weeks after ordering staff back to the office, the U.S. Food and Drug Administration (FDA) is now letting some employees work from home again.The move follows major staff cuts and resignations that threaten the agencys a.
A team has revealed new insights into the motion of massive stars in the Small Magellanic Cloud (SMC), a small galaxy neighboring the Milky Way. Their findings suggest that the gravitational pull of the Large Magellanic Cloud (LMC), the SMC's larger companion, may be tearing the smaller one apart. This discovery reveals a new pattern in the motion of these stars that could transform our understanding of galaxy evolution and interactions.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
THURSDAY, April 10, 2025 -- Your cat might not do the dishes, and your dog probably cant fix your Wi-Fi, but they could be making you just as happy as a spouse or best friend.A new study found that having a furry friend may boost your overall life.
THURSDAY, April 10, 2025 -- There are all sorts of co-ops credit unions, employee-owned businesses, utility providers, farmers cooperatives.But a new type of co-op might be the key to caring for aging Americans amid a shortage of paid car.
Altasciences Ophthalmic Expertise: A Conversation with Dr. Simone Iwabe, DVM, PhD, DACVO and Randy Wheeland, BS pmjackson Thu, 04/10/2025 - 19:59 As a leading partner in ocular therapy, Altasciences has been at the forefront of ophthalmic drug development for over 30 years, having completed more than 100 ocular studies to assess the safety of new drug products intended for human use.
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
THURSDAY, April 10, 2025 -- Night shift workers might be able to protect their heart health by only eating during daylight hours, a new study says.Participants in an experiment experienced fewer heart health risk factors if they only ate during the.
By Alexander Gaffney, MS, RAC MARTY MAKARY has been confirmed by the Senate as the next commissioner of the FDA. But Makary will almost immediately face challenges that will make his tenure as commissioner especially difficult. Here, AgencyIQ identifies and explores five of the biggest hurdles the new commissioner will face. Fill out the form to read the full article.
Explore key steps to successfully enter the European pharmaceutical market, including navigating regulatory frameworks, ensuring quality compliance, and obtaining Wholesale Distribution Authorization.
Study reveals commonly detected environmental levels of clobazam -- a medication often prescribed for sleep disorders -- increased the river-to-sea migration success of juvenile salmon in the wild. The research team employed slow-release pharmaceutical implants and animal-tracking transmitters to monitor how exposure to clobazam and the opioid painkiller tramadol -- another common pharmaceutical pollutant -- affected the behaviour and migration of juvenile Atlantic salmon (Salmo salar) in Sweden
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
"Unlock the Secrets to Dominating the Pharmaceutical Market As a seasoned pharma professional, I've seen firsthand how complex drug pricing models can be a major obstacle to success. But what if you could decode the code and gain a strategic edge over the competition? I recently came across a game-changing resource that's been a game-changer for me: Decoding Drug Pricing Models: A Strategic Guide to Market Domination.
This is the second “Data Brief” in a new series quantifying biology. All the datasets used to create this article are freely available on GitHub. Biologists have long pondered whether life can be reduced to discrete chemical components or, conversely, whether those same components could be used to assemble an organism from scratch. Perhaps in the future, human hands might tailor a cell by stitching together individual molecules with the world’s finest sewing machine.
By Sarah Wicks & Anne K. Walsh The recent and drastic Reduction In Force (RIF) at the U. S. Food and Drug Administration (FDA) is already having ripple effects not just internally, but across the broader regulatory and life sciences communities and the public at large. While much of the focus has been on how these cuts may impact application review timelines and industry engagement, see earlier post about the effect on generic drugs, another quieter consequence is emerging a significant sl
In the last blog, we discussed Integrating theOptimizely CMS website with Azure AI search. Now let’s take a bit more advanced topic to serve Personalization experience with Azure AI search with Azure personalizer. Together, they enable you to serve dynamic customized content and search results across user behaviour, preferences, and context. What is Azure Personalizer?
Ketamine Use and Driving in Northeastern France "In the present study, the overall percentage of drivers who tested positive for ketamine in a roadside oral fluid test was 2.6%. This percentage was higher than that described by Gish et al. in samples collected at a music festival in southwest France (1.4% in 2017 and 0.4% in 2019) [ 17 ], but also higher than the prevalence previously reported in the driver population of other countries [ 18 , 19 , 20 , 21 ] where the highest prevalence was foun
This guide will walk you through building a small application step-by-step, focusing on integrating several powerful tools and concepts essential for modern Android development. What We’ll Cover: Jetpack Compose: Building the UI declaratively. NoSQL Database (Firestore): Storing and retrieving data in the cloud. WorkManager: Running reliable background tasks.
Prevalence of MDMA Use in France "Lifetime use of MDMA, which also mainly affects men (11.7% compared to 4.9% of women), rose sharply between 2017 and 2023 (increasing from 5.0% to 8.2%), and its current use has doubled (from 1.0% to 1.8%), 2534-year-olds being the most likely to have tried it (13.8%). This increase was proportionally greater for women (0.6% to 1.3%) than men (1.5% to 2.4%)." dwf_admin Thu, 04/10/2025 - 14:43 Source l'Observatoire francais des drogues et des toxicomanies (OFDT).
Why Wearable Tech Is Changing Clinical Trials Wearable devices are doing more than counting stepstheyre redefining how clinical trials are. The post How Wearable Devices Improve Patient Engagement in Clinical Trials appeared first on Crucial Data Solutions.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content